Hypertensive Heart Failure Associated with Middle Aortic Syndrome Reversed Dramatically by Endovascular Management.
10.4250/jcu.2011.19.3.144
- Author:
Weon KIM
1
;
Chung Su PARK
;
Hee Jong KIM
;
Kyung Hwan KIM
;
Hye Mi AN
;
Yeon Hwa KIM
;
Chur Hoan LIM
;
Won Yu KANG
;
Sun Ho HWANG
;
Wan KIM
Author Information
1. Division of Cardiology, Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
Hypertension;
Aorta;
Heart failure;
Stent
- MeSH:
Adult;
Aorta;
Aorta, Thoracic;
Blood Pressure;
Carbazoles;
Diltiazem;
Heart;
Heart Failure;
Humans;
Hypertension;
Losartan;
Male;
Phenobarbital;
Propanolamines;
Stents;
Stroke Volume
- From:Journal of Cardiovascular Ultrasound
2011;19(3):144-147
- CountryRepublic of Korea
- Language:English
-
Abstract:
A 42-year-old male patient presented with refractory hypertension and congestive heart failure. He had taken hydrochlorthiazide 50 mg, carvedilol 25 mg, diltiazem 180 mg, and losartan 100 mg per day. Aortogram revealed a severe luminal narrowing in the distal thoracic aorta with a peak systolic pressure gradient of 60 mmHg across the lesion. Endovascular management was performed with 22 x 80 mm self-expandable Nitinol-S stent after predilation with 10 x 40 mm balloon. After endovascular management, the patient's blood pressure, left ventricular ejection fraction (LVEF) and dilated LV dimension were remarkably improved.
